Siddharth J. Modi

About

Medicinal chemistry
Pharmacology
Chemical biology
Drug Design
Pharmacy

Employment

Employment history is unavailable.

Education

• Bharati Vidyapeeth Deemed University Poona College of Pharmacy Doctor of Philosophy (Ph.D)
  2017 - Present
• Bharati Vidyapeeth Deemed University Poona College of Pharmacy M.Pharm
  2015 - 2017
• Nirma University of Science and Technology Institute of Pharmacy B.pharm
  2011 - 2015

Projects & Funding

Projects & funding information is unavailable.

Publications (13)

• Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines
  Journal of Biomolecular Structure and Dynamics 2023 DOI: 10.1080/07391102.2022.2053206
  +Save
• Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors
  Journal of Biomolecular Structure and Dynamics 2022 DOI: 10.1080/07391102.2021.1872417
  +Save
• Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS)
  Molecules 2022 DOI: 10.3390/molecules27051476
  +Save
• Evaluation of piperine against cancer stem cells (CSCs) of hepatocellular carcinoma: Insights into epithelial-mesenchymal transition (EMT)
  Bioorganic Chemistry 2021 DOI: 10.1016/j.bioorg.2021.104776
  +Save
• Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma
  European Journal of Medicinal Chemistry 2020 DOI: 10.1016/j.ejmech.2020.112851
  +Save
• Insights into the structural features of anticancer 1,6-naphthyridines and pyridopyrimidines as VEGFR-2 inhibitors: 3D-QSAR study
  Journal of Applied Pharmaceutical Science 2020 DOI: 10.7324/JAPS.2020.10101
  +Save
• Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective
  Medicine in Drug Discovery 2019 DOI: 10.1016/j.medidd.2019.100009
  +Save
• SYNTHESIS AND ANTICANCER SCREENING OF TRIAZINE ANALOGUES
  International Journal of Pharmacy and Pharmaceutical Sciences 2019 DOI: 10.22159/ijpps.2019v11i4.28275
  +Save
• 3D-QSAR analysis of pyrimidine derivatives as AXL kinase inhibitors as anticancer agents
  Journal of Applied Pharmaceutical Science 2018 DOI: 10.7324/JAPS.2018.81103
  +Save
• QSAR and molecular docking of phthalazine derivatives as epidermal growth factor receptor (EGFR) inhibitors
  Journal of Applied Pharmaceutical Science 2017 DOI: 10.7324/JAPS.2017.70427
  +Save